Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic Fibrosis - Trial NCT06413459
Access comprehensive clinical trial information for NCT06413459 through Pure Global AI's free database. This phase not specified trial is sponsored by Ospedale San Raffaele and is currently Recruiting. The study focuses on Non-Tuberculous Mycobacterial Pneumonia,Cystic Fibrosis Lung. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Ospedale San Raffaele
Timeline & Enrollment
N/A
Apr 08, 2021
Mar 30, 2027
Primary Outcome
profile of specific cell populations and expression markers to determine the development and progression of M. abscessus lung disease in patients with CF
Summary
In this project the investigators aim to identify new biological markers by characterizing
 the response/inflammation associated with the development and progression of M. abscessus
 lung disease in patients suffering from cystic fibrosis with the aim of increasing current
 knowledge available on the development and progression of lung disease.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06413459
Non-Device Trial